Kheiron wins CE Mark for breast screening AI software

By staff writers

October 2, 2018 -- U.K. start-up Kheiron Medical Technologies has received the CE Mark for its breast cancer screening machine-learning software.

The software offers users a second read for mammography images in a screening setting, the company said. Receipt of the CE Mark will allow the software to be used with the National Health Service and other European healthcare systems.

The company is in the process of applying for approval of the software through the U.S. Food and Drug Administration.

Copyright © 2018
Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking